« Back to list Overall Survival Data for Patients with Small Cell Neuroendocrine Prostate Cancer: BXCL701 Phase 2 Trial Results Oct 10, 2023 at 8:00 AM EDT Listen to Webcast Supporting Materials BXCL701 / KEYTRUDA® in Small Cell Neuroendocrine Prostate Cancer 3.6 MB